Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.

Saved in:
Bibliographic Details
Title: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.
Authors: Wang L; The Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China., Xu Y; The Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China.; Department of Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, People's Republic of China., Zhao Y; Department of Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, People's Republic of China., Xia B; Department of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China., Zhu L; Department of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China. zhulucheng1@zuaa.zju.edu.cn.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Oct 10; Vol. 74 (11), pp. 334. Date of Electronic Publication: 2025 Oct 10.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-025-04158-1